menu
    • menu

    Company profile for Trevena

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Trevena, Inc. (NASDAQ: TRVN) is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders. Trevena’s novel pipeline includes product candidates aimed at moderate-to-severe acute pain, migraine, opioid use disorder, and other CNS indications. All of the company’s assets have unique mechanisms of action (MOA) that are designed to o...
    Trevena, Inc. (NASDAQ: TRVN) is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders. Trevena’s novel pipeline includes product candidates aimed at moderate-to-severe acute pain, migraine, opioid use disorder, and other CNS indications. All of the company’s assets have unique mechanisms of action (MOA) that are designed to optimize receptor pharmacology. Trevena’s novel pipeline includes product candidates aimed at moderate-to-severe acute pain, migraine, opioid use disorder, and other CNS indications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TrevenaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    955 Chesterbrook Blvd Suite 110 Chesterbrook, PA 19087
    Telephone
    Telephone
    (610) 354-8840
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.trevena.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/trevena-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Trevena Reports Q3 2024 Results & Provides Business Update
    Trevena Reports Q3 2024 Results & Provides Business Update

    07 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/07/2976530/0/en/Trevena-Reports-Third-Quarter-2024-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    07 Nov 2024
    Share Share
    Trevena Announces Receipt of Nasdaq Delisting Notification
    Trevena Announces Receipt of Nasdaq Delisting Notification

    04 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/04/2958504/0/en/Trevena-Announces-Receipt-of-Nasdaq-Delisting-Notification.html

    GLOBENEWSWIRE
    04 Oct 2024
    Share Share
    Trevena Announces Reverse Stock Split
    Trevena Announces Reverse Stock Split

    08 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/08/2927314/0/en/Trevena-Announces-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    08 Aug 2024
    Share Share
    Trevena Reports Second Quarter 2024 Results and Provides Business Update
    Trevena Reports Second Quarter 2024 Results and Provides Business Update

    08 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/08/2926769/0/en/Trevena-Reports-Second-Quarter-2024-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    08 Aug 2024
    Share Share
    Trevena Announces $2M Non-Dilutive Financing And Liability Reduction
    Trevena Announces $2M Non-Dilutive Financing And Liability Reduction

    08 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/08/2909702/0/en/Trevena-Announces-2M-Non-Dilutive-Financing-Tranche-and-Reduction-in-Outstanding-Liabilities-in-Connection-with-Existing-ex-US-Royalty-Financing.html

    GLOBENEWSWIRE
    08 Jul 2024
    Share Share
    Trevena Reports Positive TRV045 Data In Pain And Epilepsy Preclinical Models
    Trevena Reports Positive TRV045 Data In Pain And Epilepsy Preclinical Models

    20 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/20/2901542/0/en/Trevena-Announces-Preclinical-TRV045-Data-Providing-Insight-Into-Novel-Mechanism-of-Analgesic-Effect-in-Chronic-Neuropathic-Pain-Model-and-Demonstrating-Statistically-Significant-A.html

    GLOBENEWSWIRE
    20 Jun 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search